Concepedia

Randall K. Rader

RK

10

Publications

764

Citations

10

H-Index

1989

Active since

Affiliations

Pfizer (United States)(Current)

Monsanto (United States)

Randall K. Rader is an author at Pfizer (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1989–2010

10

Publications

10

Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticles

Stasia A. Anderson, Randall K. Rader, William Westlin et al. · Magnetic Resonance in Medicine · 2000 · 273 citations · Full text

, , +15

A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis

John F. Harms, Danny R. Welch, Rajeev S. Samant et al. · Clinical & Experimental Metastasis · 2004 · 111 citations

Experimental ischemia induces a persistent depolarization blocked by decreased calcium and NMDA antagonists

Randall K. Rader, Thomas H. Lanthorn · Neuroscience Letters · 1989 · 96 citations

, , +13

Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis

Jeffrey D. Peterson, Timothy P. LaBranche, Kristine Vasquez et al. · Arthritis Research & Therapy · 2010 · 67 citations · Full text

T cell activation is regulated by voltage-dependent and calcium-activated potassium channels

Randall K. Rader, Luisa Kahn, Göran Anderson et al. · The Journal of Immunology · 1996 · 63 citations · Full text

Rows per page

1–5 of 10